Offer - Urjas Oil for just ₹ 1 X
Glimet 2.5 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Glimet 2.5 Tablet have also been mentioned below.
The right dosage of Glimet 2.5 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Glimet 2.5 Tablet are Stomach Upset, Difficulty urinating. Apart from the aforementioned side effects, Glimet 2.5 Tablet can also lead to other problems, which have been listed below. Such side effects of Glimet 2.5 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Glimet 2.5 Tablet is Mild for pregnant women and Moderate for women who are breastfeeding. Further, the section on Glimet 2.5 Tablet related warnings talks about Glimet 2.5 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease, Heart Disease, Kidney Disease must refrain from the use of Glimet 2.5 Tablet since this can cause severe adverse effects. Other contraindications of Glimet 2.5 Tablet have been discussed in the sections ahead.
Drug reaction of Glimet 2.5 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Glimet 2.5 Tablet is safe while driving, and is is addictive in nature.
Glimet 2.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimet 2.5 Tablet safe for pregnant women?
Pregnant women may get mild side effects from Glimet.
Is the use of Glimet 2.5 Tablet safe during breastfeeding?
Glimet can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Glimet 2.5 Tablet on the Kidneys?
Glimet is completely safe for kidneys.
What is the effect of Glimet 2.5 Tablet on the Liver?
Glimet does not damage the liver.
What is the effect of Glimet 2.5 Tablet on the Heart?
Glimet is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Glimet 2.5 Tablet unless your doctor advises you to do so -
Is this Glimet 2.5 Tablet habit forming or addictive?
No, you will not get addicted to Glimet 2.5 Tablet.
Interaction between Food and Glimet 2.5 Tablet
There is no information on the effects of taking Glimet 2.5 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glimet 2.5 Tablet
Taking Glimet 2.5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucotrol - glipizide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826